Background/Aims: Conjugated linoleic acids (CLAs) are known to induce apoptosis in different apoptotic induction effects of two CLA isomers on adipocytes and then investigated the expression and function of microRNAs (miRNAs) related to the apoptosis. Methods: TUNEL and FCM assays were used to detect CLAs-induced adipocyte apoptosis. Microarrays were used to compare the differential expression of miRNAs. MiR-23a, a miRNA that showed functional studies via over-expression and knock down in in vivo and in vitro experiments. Results: C9, t11-CLA exhibited a stronger induction of apoptosis in the differentiated 3T3-L1 adipocytes than t10, c12-CLA. However, t10, c12-CLA could rapidly activate NF-B, which may have caused their different apoptotic effects. MiR-23a was markedly down-regulated by the CLAs treatment and miR-23a over-expression attenuated CLA-induced apoptosis. Apoptosis in vivo experiment endogenous miR-23a was down-regulated in mice fed with a mixture of both CLAs. The mice also exhibited less fat deposition and more apoptotic fat cells in adipose tissue. Moreover, endogenous miR-23a was suppressed in mice via intravenous injection with an antagomir which resulted in decreased body weight, increased number of apoptotic fat cells and increased APAF1 expression in adipose tissue. Conclusion: Taken together, our results suggest that miR-23a plays a critical role in CLA-induced apoptosis in adipocytes via controlling APAF1 expression.
Introduction
Natural conjugated linoleic acids (CLAs) are a mixture of positional and geometric isomers (cis or trans) of linoleic acid with conjugated double bonds. Accumulating evidence suggests that CLAs have a diverse range of biological functions including the enhancement of immunity [1] , prevention of tumor formation [2, 3] , and the reduction of body fat deposition [4] [5] [6] .
Currently, obesity and related metabolic disorders caused by excessive fat deposition are becoming a growing public health crisis. CLAs show strong anti-obesity actions in humans and animals. They have been shown to inhibit the differentiation process of preadipocytes and reduce the triglyceride content of mature or newly differentiated adipocytes as well as induce adipocytes apoptosis [7] [8] [9] [10] . Cis-9, trans-11 (c9, t11)-CLA and t10, c12-CLA are two primary isomers of CLA that have different biological properties. T10, c12-CLA generally has a much stronger anti-adipogenesis effect than c9, t11-CLA.
As apoptotic inducers, CLAs have strong anti-cancer effects on various tumor cells. C9, t11-CLA and t10, c12-CLA either directly activate the caspase cascade of apoptosis or promote apoptotic signal transmission [11, 12] . However, little is known about the effects of CLAs on apoptosis in adipocytes. Several pieces of evidence suggest that CLAs directly induce apoptosis in adipocytes such as the 3T3-L1 cell line or mouse fat cells [8, 13, 14] . Furthermore, we have also found that dietary supplementation with CLAs decreases back fat accumulation in piglets partially through apoptosis induction in adipocytes [15] . However, the underlying details of this mechanism are unclear and require further studies.
MicroRNAs (miRNAs) are small non-coding RNAs that are 18-25 nt in length. miRNAs are widely expressed in a diverse range of animal tissues and are involved in the posttranscriptional expression regulation of numerous target genes [16] . Depending on their regulatory target, many miRNAs play important role in the apoptosis of various cell types via the control of pro-or anti-apoptotic molecules [17] [18] [19] . It has also been recently shown that nutritional and dietary factors such as CLA alter the expression levels of miRNAs [20, 21] . However, it remains unclear which miRNAs and regulatory pathways are affected by CLA.
This study aimed to explore and compare the differential effects of the two CLAs on adipocyte apoptosis and which miRNAs were implicated in the process. We found that c9, t11-CLA had a stronger apoptosis induction effect than t10, c12-CLA. This difference likely regulated by the CLAs, whereas miR-23a over-expression attenuated the apoptosis induction effect of CLA by targeting the APAF1 gene. An in vivo study in mice also showed that dietary supplementation with CLA increased the number of apoptotic adipocytes and decreased fat deposition at least in part through the altered expression of miR-23a/APAF1. Together, these CLA and has the potential to be a new target for obesity therapy. 
Materials and Methods

Cell culture
MiRNA microarray analysis
To compare the differences in miRNA expression in CLA-treated cells and normal cells, a commercial
Microarray-Single following the manufacturer's instructions. After hybridization, the arrays were subjected
Cell transfection
transfected into cells for over-expression (miR-23a mimic) or knock-down (miR-23a inhibitor) of miR-23a.
Mouse experiment
For the in vivo divided into 3 groups and fed either a high-fat diet alone (control group and antagomir group, 45% kcal from fat) or high-fat + CLA diet (CLA group, CLA dose in diet, 15 g/kg; c9, t11-CLA:t10, c12-CLA=1:1 in used to silence the endogenous miR-23a. After high-fat feeding for 30 days, all mice in the antagomir group injection. The mice were injected 3 times, with one injection every 5 days. During the experimental period, the body weight and food intake of the mice were measured every 15 days. At the 45th day, all mice were cytoplasm, which activated caspase 3/7, a key player in apoptosis ( Fig. 2C and D) . Additionally, tumor necrosis factor (TNF ) was highly expressed in CLA-treated cells. The expression of the TNF directly induces apoptosis in many cell types by activating the death receptor signaling cascade [22, 23] . Therefore, changes in the expression of these regulators suggested that apoptotic signaling was activated by CLA in adipocytes and was transmitted through the mitochondrial showed more powerful inhibition effects on fat production and adipogenesis differentiation.
To further explore the differential apoptotic induction effects between the two CLA cell types [24] [25] [26] . We found that t10, c12-CLA, but not c9, t11-CLA, induced the activation I suggested that the apoptotic induction effect of t10, c12-CLA may be partly attenuated by
CLAs altered miRNA expression in 3T3-L1 adipocytes P < 0.05). C9, t11- 
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760, miR-6963, miR-6904, miR-7063 and miR-8114). T10, c12-CLA also down-regulated miR-23a, miR-28c, and Let-7a expression levels, whereas it had the opposite effect on the other seven miRNAs. The qRT-PCR data corroborated these changes in miRNA expression the advance and onset of apoptosis.
Over-expressed miR-23a attenuated CLA-induced apoptosis in adipocytes
Additionally, previous studies have reported that miR-23a participates in apoptosis in other cell types [27] [28] [29] . Therefore, we further examined the role of miR-23a in adipocyte 23a, respectively. In the mimic group, miR-23a expression was up-regulated 14.5-fold in 3T3-L1 adipocytes, while it was down-regulated more than 90% following inhibitor transfection (Fig. 5A) . Moreover, the mimic rescued the expression of miR-23a in adipocytes treated with CLA, and the compensatory expression greatly impeded the apoptosis induced by the apoptosis induced by CLA. We found that the miR-23a inhibitor also directly increased the expression of cleaved caspase 3/7, cytochrome C, and cleaved poly (ADP-ribose) polymerase (PARP) protein (Fig.   Fig. 2 . a direct role in adipocyte apoptosis. Therefore, CLA-induced apoptosis in adipose tissue may occur partly through altered miR-23a expression.
were potential targets of miR-23a. However, qPCR and western blotting results showed reporter assay showed that co-transfection of Luc-APAF1 with the miR-23a mimic decreased luciferase activity by 58% compared to control. Transfection with the APAF1 mutant did not regulated APAF1 expression by binding its 3 -untranslated region (Fig. 6C and D) . Therefore, we believe APAF1 is a direct target of miR-23a during the apoptotic process.
Supplementing CLA and silencing miR-23a decreased fat deposition in mice, partly through inducing the apoptosis of adipocytes
To further evaluate the effects of CLA and miR-23a on obesity and fat deposition, an in vivo study was conducted in mice (Fig. 7A) . As expected, supplementing a CLA mixture as expected, fat tissues of CLA-fed mice had lower levels of miR-23a, higher caspase 3/7 approximately 80% 12 h after the antagomir injection, and the effect of one injection lasted P <0.05) compared with control mice, even though they were fed the same high-fat chow. Similar to CLA treatment, miR-23a silencing also increased caspase 3/7 activity (1.7-fold) and the number of fat cells undergoing apoptosis compared with control mice. As expected, we also observed increases in APAF1 mRNA and protein expression following miR-23a silencing (Fig. 8) . These results suggested that the in vivo anti-obesity effects of CLA occur, at least in part, through apoptosis induced in fat cells and alterations in the expression of apoptosis-related miRNAs and their targets, such as miR-23a/APAF1.
Discussion
Research into the apoptosis of adipocyte will help us combat obesity and related metabolic syndromes, but little is known about how CLA induces adipocyte apoptosis or which target genes are involved. Here, we found that t10, c12-CLA inhibited cellular differentiation and lipid production in pre-adipocytes and adipocytes to a greater extent than c9, t11-CLA. However, contrary to earlier work [13, 14], we showed that c9, t11-CLA exhibited stronger induction effects than t10, c12-CLA on mature adipocytes with the same differentiation or differences in detection methods. Indeed, c9, t11-CLA also exhibited a strong apoptosis induction action in other cells [30, 31] .
Activated NFapoptosis in many cell types. Tamai et al (2000) found suppression of NFleading to the activation and nuclear translocation of NFof NFthat only t10, c12-CLA could activate the NFrelated molecular mechanisms of the two CLAs and partly answer the reason for differential apoptosis induction effects between different CLA isomers.
to regulate the cell proliferation, differentiation, and apoptosis [16, 36, 37] . In the present miRNAs between the two CLA-treated cells may explain why the two CLA isomers distinct differences on function.
MiR-23a has previously been proposed as a key apoptosis-related molecule, and we studies have suggested it was a molecular marker for a variety of cancers because of its high expression in tumor cells [38, 39] . Moreover, it is also known to control the initiation indicated that it also played a pivotal role in adipocyte apoptosis through control of APAF1 expression.
on mature adipocytes, though t10, c12-CLA exhibits more forceful inhibition effects on differentiation and fat production in pre-adipocytes. MiR-23a is down-regulated by CLAs in adipocytes, which increases the expression of APAF1, leading to apoptosis.
